DIAMOND BIOFUND INC - Asset Resilience Ratio
DIAMOND BIOFUND INC (6901) has an Asset Resilience Ratio of 12.12% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of DIAMOND BIOFUND INC to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how DIAMOND BIOFUND INC's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see DIAMOND BIOFUND INC total assets.
Liquid Assets Composition Over Time
This chart breaks down DIAMOND BIOFUND INC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of DIAMOND BIOFUND INC for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$1.13 Billion | 12.12% |
| Total Liquid Assets | NT$1.13 Billion | 12.12% |
Asset Resilience Insights
- Moderate Liquidity: DIAMOND BIOFUND INC has 12.12% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
DIAMOND BIOFUND INC Industry Peers by Asset Resilience Ratio
Compare DIAMOND BIOFUND INC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Blue Star Capital plc
LSE:BLU |
Asset Management | 16.18% |
|
FS KKR Capital Corp
NYSE:FSK |
Asset Management | 0.13% |
|
Oakley Capital Investments Limited
LSE:OCI |
Asset Management | 4.74% |
|
Source Capital Closed Fund
NYSE:SOR |
Asset Management | 19.45% |
|
Ocean Wilsons Holdings Ltd
LSE:OCN |
Asset Management | 35.27% |
|
US Global Investors Inc
NASDAQ:GROW |
Asset Management | 20.76% |
|
Eurocastle Investment Ltd
AS:ECT |
Asset Management | 0.29% |
|
BlackRock Inc
NYSE:BLK |
Asset Management | 8.39% |
Annual Asset Resilience Ratio for DIAMOND BIOFUND INC (2019–2025)
The table below shows the annual Asset Resilience Ratio data for DIAMOND BIOFUND INC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 12.12% | NT$1.13 Billion ≈ $35.75 Million |
NT$9.36 Billion ≈ $294.85 Million |
-34.75pp |
| 2024-12-31 | 46.88% | NT$5.00 Billion ≈ $157.65 Million |
NT$10.67 Billion ≈ $336.31 Million |
-10.97pp |
| 2023-12-31 | 57.85% | NT$7.54 Billion ≈ $237.68 Million |
NT$13.04 Billion ≈ $410.89 Million |
-35.09pp |
| 2022-12-31 | 92.94% | NT$10.40 Billion ≈ $327.79 Million |
NT$11.19 Billion ≈ $352.69 Million |
-1.85pp |
| 2021-12-31 | 94.79% | NT$10.07 Billion ≈ $317.24 Million |
NT$10.62 Billion ≈ $334.68 Million |
+9.31pp |
| 2020-12-31 | 85.48% | NT$7.93 Billion ≈ $249.93 Million |
NT$9.28 Billion ≈ $292.38 Million |
+58.10pp |
| 2019-12-31 | 27.38% | NT$843.00 Million ≈ $26.56 Million |
NT$3.08 Billion ≈ $97.02 Million |
-- |
About DIAMOND BIOFUND INC
Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.